TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
351,970
|
469,252
|
372,717 |
| Earnings before taxes |
64,031
|
206,676
|
175,333 |
| Total assets |
433,476
|
406,844
|
365,681 |
| Current assets |
304,268
|
280,374
|
258,796 |
| Current liabilities |
277,620
|
232,034
|
140,270 |
| Equity capital |
91,707
|
107,248
|
161,912 |
| - share capital |
14,888
|
14,965
|
13,753 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
21.2%
|
26.4%
|
44.3% |
| Turnover per employee |
2,346
|
3,128
|
2,485 |
| Profit as a percentage of turnover |
18.2%
|
44.0%
|
47.0% |
| Return on assets (ROA) | |||
| Current ratio |
109.6%
|
120.8%
|
184.5% |
| Return on equity (ROE) |
69.8%
|
192.7%
|
108.3% |
| Change turnover |
-114,879
|
63,684
|
372,717 |
| Change turnover % |
-25%
|
16% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.